Biochemical markers of myocardial injury

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 1, 2007, Pages 10-17

  Nigam, P K ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cardiac markers; Myocardial infarction

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CARBONATE DEHYDRATASE III; CREATINE KINASE; CREATINE KINASE ISOENZYME; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE B; ISOENZYME; LACTATE DEHYDROGENASE; MYOGLOBIN; TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIOVASCULAR SYSTEM EXAMINATION; DIAGNOSTIC ACCURACY; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HEART MUSCLE INJURY; HOSPITALIZATION; HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 33947100852     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912874     Document Type: Article

References (79)

1. Nomenclature and criteria for diagnosis of Ischaemic Heart Disease : Report of the Joint International Society and Federation of Cardiology / World Health Organization Task Force on standardization of clinical nomenclature. Circulation 1979;59: 607-08.
2. Alpert JS, Thygeson K, Antman E, et al. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology / American College of Cardiology Committee for redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
3. Mc Queen MJ, Holdir D, El-Maraglin NR. Assessment of the accuracy of serial electrocardiograms in the diagnosis of myocardial infarction. Am Heart J 1983;105:258-61.
4. Armstrong SC. Protein kinase activation and myocardial ischaemia/reperfusion injury. Cardiovasc Res 2004;61:427-36.
5. th edn. William Heinemann Medical Books Ltd. London 1984; p685-770.
6. Baron DN, Bell JL, Oakley C. Serum transaminase in coronary thrombosis and other conditions. J Clin Path 1956;9: 389-90.
7. Agress CM. Evaluation of the transaminase test. Am J Cardiol 1979; 3:74-93.
8. Kachmar JR. Enzymes, In : Fundamentals of Clinical Chemistry, NW. Tietz, Editor Sounders, Philadelphia 1976;p 674.
9. Sacks HJ, Lanchantin GF. An elevation of serum transaminases in jaundice states. Am J Clin Path. 1960;33:97-108.
10. Elliot BA, Wilkinson JH, Serum "α-hydroxybutyric dehydrogenase" in myocardial infarction and in liver disease. Lancet 1961;1:698-99.
11. Ebashi S, Toyokura Y, Momoi H, Sugita H. High creatine phosphokinase activity of sera of progressive muscular dystrophy. J Biochem (Japan) 1959;46: 103-05.
12. Doran GR, Wilkinson JH. The origin of the elevated activities of creatine kinase and other enzymes in the sera of patients with myxedema Clin Chim Acta 1975;62: 203-07.
13. Zsigmond EK, Starkweather WH, Duboff GS, Flynn KA. Elevated Serum Creatine Phosphokinase activity in a family with malignant hyperpyrexia. Anesth Analg 1972;51: 827.
14. LaFair JS, Myerson RM. Alcoholic myopathy. Arch Intern Med 1968; 122: 417-19.
15. Dubo H, Park DC, Pennigton R, JT Kalbag RM, Walton JN. Serum creatine kinase in cases of stroke, head injury and meningitis. Lancet 1967;2: 743-48.
16. Vassella F, Richterich R, Rossi E. The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Paediatrics 1965;35: 322-30.
17. Lee TH, Goldman L. Serum enzymes assay in the diagnosis of acute myocardial infarction. Recommendation based on a quantitative analysis. Ann Intern Med 1986; 105: 221-33.
18. Seckinger DL, Vazquez DA, Rosenthal PK, Mendizabal RC. Cardiac isoenzyme methodology and the diagnosis of acute myocardial infarction. Am J Clin Pathol 1983; 80: 164-69.
19. Roberts R. Enzymatic diagnosis of acute myocardial infarction. Chest 1988;93: 3S-6S.
20. Collison PO, Rosalki SB, Kuwana T et al. Early diagnosis of acute myocardial infarction by CK-MB mass measurements. Ann Clin Biochem 1992;29:43-47.
21. Lott JA, Heinz JW, Reger KA. Time changes of creatine kinase and creatine kinase MB isoenzyme versus discrimination values in the diagnosis of acute myocardial infarction : what is the optimal method for displaying the data? Eur J Clin Chem Biochem 1995; 33: 491-96.
22. Panteghini M. Diagnostic application of CK-MB mas determination. Clin Chim Acta 1998;272:23-31.
23. Ravkilde J, Hansen AB, Horder M, Jorgensen PJ, Thygesen K. Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for creatine kinase isoenzyme MB. Cardiology 1992;80: 143-51.
24. Grande P, Granborg J, Clemmensen P, Sevilla DC, Wagner NB, Wagner GS. Indices of reperfusion in patients with acute myocardial infarction using characteristics of the CK-MB time activity curve. Am Heart J 1991; 122:400-08.
25. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR. Cardiac troponin T and I and creatine kinase - MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 2003;92: 285-93.
26. El Allaf M, Chapelle JP, El Allaf E et al. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clin Chem 1986;32:291-95.
27. Thrompson WG, Mahr RG, Yohannan WS, Pincus MR. Use of creatine kinase MB isoenzyme for diagnosing myocardial infarction when total creatine kinase activity is high. Clin Chem 1988; 34: 2208-10.
28. Keffer JH. Myocardial markers of injury-evolution and insights. Am J Clin Pathol 1996; 105:305-20.
29. Arenas J, Diaz V, Liras G. et al Activities of creatine kinase and its isoenzymes in serum in verious skeletal muscle disorders. Clin Chem 1988; 34: 2460-62.
30. Puleo PR, Guadagno PA, Roberts R et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase - MB. Circulation 1990;82: 759-64.
31. Puleo PR, Meyer D, Wathen C et al. Use of a rapid assay of subforms of creatine kinase MB to diagnose or rule out acute myocardial infarction. N Engl J Med 1994; 331: 561-66.
32. Panteghini M. Serum isoforms of creatine kinase isoenzymes. Clin Biochem 1988;21:211-18.
33. Wu ABW. Creatine kinase isoforms in ischaemic heart disease. Clin Chem 1989; 35:7-13.
34. Prager NP, Suzuki T, Jaffe AS, Sobel BE, Abendschein DR. The nature and time course of generation of the isoforms of MB creatine kinase in vivo. J Am Coll Cardiol 1992; 20: 414-19.
35. Pentilla K, Koukkunen H, Halinen M, Rantanen T, Pyorala K, Punnone PI. Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clin Biochem 2002; 35: 647-53.
36. Christenson RH, Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem 1998; 44: 1855-1864.
37. Gilkeson G, Stone MJ, Waterman M, Ting R, Gomez-Sanchez CE, Hull A, Willerson JT. Detection of myoglobin by radioimmunoassay in human sera : Its usefulness and limitations as an emergency room screening test for acute myocardial infarction. Am Heart J 1978; 95:70-75.
38. deWinter, Koster R, Sturk A, Sanders G. Value of myoglobin, troponin T and CKMB m in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92: 3401-07.
39. Hetland O, Dickstein K. Cardiac markers in the early h of acute myocardial infarction : clinical performance of creatine kinase, creatine kinase MB isoenzyme (activity and mass concentration), creatine kinase MM and MB isoform ratios, myoglobin and cardiac troponin T. Scand J Clin Lab Invest 1996; 56:701-13.
40. Jernberg T, Lindahl B, James S, Ranquist G, Wallentin L. Comparison between strategies using creatine kinase - MB (mass), myoglobin and troponin T in the early detection or exclusion of acute myocardial infarction in patients with chest pain and a non-diagnostic electrocardiogramm. Am J Cardiol 2000; 86: 1367-71.
41. Mair J, Morandell D, Genser N, Lechleitner P, Dienstl F, Puschendorf B. Equivalent early sensitivities of myoglobin, creatine kinase MB-mass, creatine kinase isoform ratios and cardiac tropinim I and T for acute myocardical infarction. Clin Chem 1995; 41:1266-72.
42. Zimmerman J, Fromm R, Meyer D. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-77.
43. Pantighini M. Biochemical markers in acute coronary syndromes. LabMedica International 2003;20(6): 6-7.
44. Katus HA, Remppis A, Scheffold T, Dienderich KW, Kubler W. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and non-reperfused myocardial infarction. Am J Cardial 1991;67: 1360-67.
45. Adams JE, Schechtman KB, Landt Y et at. Comparable detection of AMI by CK-MB isoenzyme and cardiac tropnin I. Clin Chem 1994; 40: 1291-95.
46. Tymchak WJ, Armstrong PW. Spectrum of ischaemic heart disease and the role of biochemical markers. Clin Lab Med 1997; 17: 701-25.
47. Rottbauer W, Greten T, Muller-Bard off M et al. Troponin T:A diagnostic marker for myocardial infarction and minor cell damage. Eur Heart J 1996; 17: (Suppl. F), 3-8.
48. Hamm CW. Cardiac-specific troponins in acute coronary syndromes in Braunwald, E (ed.) Heart Disease: A text-book of cardiovascular Medicine. 5th ed 1997 Update vol.3. p 1-10.
49. Ravikilde J, Horder M, Gerhardt W, Ljungdahl J, Petterson T, Tryding N et al. Diagnostic performance and prognostie value of serum Troponin T in suspected acute myocardial infarction. Send J Clin Lab Invest 1993; 53: 677-85.
50. Wu AHB, Feng YJ, Controls JH. Prognostic value of cardiac troponin I in chest pain patients. Clin Chem 1996;42:651-52.
51. Galvani M, Ottari F, Ferrini D, Ladenson, JH, Destro A, Baccos D et at. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95: 2053-59.
52. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW et al. Cardiac troponin T levels for risk stratification in acute ischaemia. N Engl J Med 1996; 335: 133-41.
53. Olatidoye AG, Wu AH, Feng Y, Waters D. Prognostic role of Troponin T versus Troponin I in unstable Agnina Pectoris for cardiac events with meta-analysis comparing Published studies. Am J Cardiol 1998;81:1405-10.
54. Heidenreich PA, Allogiamento T, Melsop K, McDonald KM, Alan SGo, Heatky MA. The prognostic valve of troponin in patients with non-ST elevation acute coronary syndromes: a meta analysis. J Am Coll Cardiol 2001;38: 478-85.
55. Rao SV, Ohman EM, Granger CB et al. Prognostic value of isolated troponin elevations across the spectrum of chest pain syndromes. Am J Cardiol 2003;91:936-40.
56. Apple FS, Henry TD, Berger CR, Landt YA. Early monitoring of serum cardiac Troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Path 1996;105: 6-10.
57. Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Waldes R Jr. National Academy of Clinical Biochemistry standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999;45: 1104-21.
58. Bodor GS, Porterfield D, Voss E. et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle (Abstract) Clin Chem 1995; 41: s148.
59. Ikeda J, Zenimoto M, Kita M, Mori M. Usefulness of cardiac troponin I in patients with acute myocardial infarction. Rinsho Byori 2002;50: 982-86.
60. Sciries BM, Morrow DA. Troponins in acute coronary syndromes. Prog Cardiovasc Dis 2004; 47:177-88.
61. Vaananen HK, Syrjala H, Rahkila P et al. Serum carbonic anhydrase III and myoglobin concentration in acute myocardial infarction. Clin Chem 1990; 36: 635-38.
62. Brogan GX Jr, Vuori J, Friedman S, Mc Cuskey CF, Thode HC Jr, Vaananen HK, Colling DS, Bock JL. Improved specificity of myoglobin plus carbonic anhydrase assary versus that of creatine kinase-MB for early diagnosis of acute myocardial infarction. Am Emerg Med 1996; 28: 245-46.
63. Beuerle JR, Azzazy HM, Styba G, Duh SH, Christenson RH. Characteristics of myoglobin, Carbonic anhydrase III and the myoglobin/ arbonic anhydrase III ratio in trauma, exercise and myocardial infarction patients. Clin Chim Acta 2000; 294: 115-28.
64. Vuotikka P, Uusimaa P, Niemela M, Vaananen K, Vuori J, Peuhkurinen, K. Serum myoglobin/Carbonic anhydrase III ration as a marker of reperfusion after myocardial infarction. Int J Cardiol 2003; 91: 137-44.
65. Krause EG, Rabitzsch G, Noll F, Mair J, Puschendorf B. Ghycogen phophorylase ischaemic injury and infarction. Mol Cell Biochem 1996;160-161: 289-95.
66. Mair J. Glycogen phophorylase isoenzyme BB to diagnose ischaemic myocardial damage. Clin Chem Acta 1998; 272: 79-86.
67. Mair J, Puschendorf B, Smidt J, Lechleitner P, Diestl F, Noll F et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alteration. Br Heart J 1994; 72: 125-27.
68. Mair P, Mair J, Krause EG Balogh D, Puschendorf B, Rabitzsch G. Ghycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur J Clin Chem Biochem 1994;32: 543-47.
69. Wu AH. Analytical and clinical evaluation of new diagnostic tests for myocardial damage. Clin Chem Acta 1998;272: 11-21.
70. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Vander Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infaction in man. Mol Cell Biochem 1992; 116: 155-62.
71. Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, Iwase M, Kondo T, Nomura M, Nagamura Y, Watanabe Y, Hishida H, Tanaka T, Kawamura K. Serum concentrations of myoglobin Vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997;43: 1372-78.
72. Okamoto F, Sohmiya K, Ohkaru Y, Kawamura K, Asayma K, Kimura H, Nishimura S, Ishii H, Sunahara N, Tanaka T. Human heart- type cytoplasmic fatty acid binding protein (HFABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in Comparison with myoglobin and creatine Kinase isoenzyme MB. Clin Chem Lab Med 2000; 38: 231-38.
73. Chan CP, Sanderson JE, Glatz JF, Chang WS, Hempel A, Renneberg R. A superior early myocardial infarction marker Human heart-type fatty acid binding protein. Z Kardiol 2004;93: 388-97.
74. Seino Y, Tomita Y, Takano T, Ohbayashi K. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: Comparison between heart-type fatty acid binding protein and Troponin T tests. Circ J 2004;68:144-48.
75. Hasegawa T, Yoshimura N, Oka S, Ootaki Y, Toyoda Y, Yamaguchi M. Evaluation of heart fatty acid-binding protein as rapid indicator of assessment of myocardial damage in pediatric cardiac surgery. Thorac Cardiovasc Surg 2004;127: 1697-02.
76. Isobe M, Nagai R, Ueda S et al. Quantitative relationship between left ventricular function and serum cardiac myosin light chain I level after coronary reperfusion in patients with acute myocardial infarction. Circulation 1987;76: 1251-61.
77. Panteghini M. Cardiac myosin light chains. Lab Med 1992; 23: 318-322.
78. Usui A, Kato K, Sara H, Minaguchi K, Abe T, Murase M, Tanaka M, Takeuchi E. S-100 a O protein in serum during acute myocardial infarction. Clin Chem 1990;36: 639-41.
79. Kaneko N, Matsuda R, Hosoda S, Kajita T, Ohta Y. Measurement of plasma annexin V by ELISA in early detection of acute myocardial infarction. Chin Chim Acta 1996;251: 65-80.